Nisa Investment Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11K | Buy |
3,021
+2,355
| +354% | +$8.57K | ﹤0.01% | 2220 |
|
2025
Q1 | $1.28K | Buy |
666
+66
| +11% | +$127 | ﹤0.01% | 2576 |
|
2024
Q4 | $1.14K | Hold |
600
| – | – | ﹤0.01% | 2650 |
|
2024
Q3 | $792 | Buy |
+600
| New | +$792 | ﹤0.01% | 2626 |
|
2022
Q2 | – | Sell |
-1,608
| Closed | -$1K | – | 2368 |
|
2022
Q1 | $1K | Sell |
1,608
-354,600
| -100% | -$221K | ﹤0.01% | 2350 |
|
2021
Q4 | $709K | Sell |
356,208
-6,000
| -2% | -$11.9K | 0.01% | 927 |
|
2021
Q3 | $1.04K | Hold |
362,208
| – | – | 0.01% | 894 |
|
2021
Q2 | $1.37K | Buy |
362,208
+20,000
| +6% | +$76 | 0.01% | 826 |
|
2021
Q1 | $1.16K | Hold |
342,208
| – | – | 0.01% | 901 |
|
2020
Q4 | $958K | Buy |
342,208
+335,950
| +5,368% | +$940K | 0.01% | 943 |
|
2020
Q3 | $16K | Buy |
6,258
+4,650
| +289% | +$11.9K | ﹤0.01% | 2060 |
|
2020
Q2 | $22K | Buy |
1,608
+380
| +31% | +$5.2K | ﹤0.01% | 1756 |
|
2020
Q1 | $9K | Hold |
1,228
| – | – | ﹤0.01% | 1861 |
|
2019
Q4 | $8K | Hold |
1,228
| – | – | ﹤0.01% | 1862 |
|
2019
Q3 | $5K | Buy |
1,228
+850
| +225% | +$3.46K | ﹤0.01% | 1892 |
|
2019
Q2 | $2K | Hold |
378
| – | – | ﹤0.01% | 1970 |
|
2019
Q1 | $3K | Hold |
378
| – | – | ﹤0.01% | 1964 |
|
2018
Q4 | $2K | Buy |
+378
| New | +$2K | ﹤0.01% | 1905 |
|